Hims & Hers Health Inc. buy Barclays PLC
Start price
08.12.25
/
50%
€33.75
Target price
08.12.26
-
Performance (%)
-19.17%
Price
20.08.26
€27.28
Summary
This prediction is currently active. The prediction for Hims & Hers Health Inc. disappoints with a performance of -19.17%. This prediction currently runs until 08.12.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | 2.621% | 2.621% |
| iShares Core DAX® | -1.059% | 5.007% |
| iShares Nasdaq 100 | -2.387% | 0.864% |
| iShares Nikkei 225® | -4.361% | 1.211% |
| iShares S&P 500 | -1.778% | 1.391% |
Comments by Barclays_PLC for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Stopped prediction by Barclays_PLC for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€27.88
17.06.26
17.06.26
-
17.06.27
17.06.27
-2.15%
20.08.26
20.08.26
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€22.94
11.03.26
11.03.26
€24.96
11.03.27
11.03.27
18.92%
20.08.26
20.08.26